Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick P Michel

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Plos One|May 3, 2013
Bee venom and its component apamin as neuroprotective agents in a Parkinson disease mouse modelDaniel Alvarez-Fischer, Carmen Noelker, Franca Vulinović, et al.
Journal of Medicinal Chemistry|June 25, 2016
New 6-Aminoquinoxaline Derivatives with Neuroprotective Effect on Dopaminergic Neurons in Cellular and Animal Parkinson Disease ModelsGael Le Douaron, Laurent Ferrié, Julia E Sepulveda-Diaz, et al.
Neuroscience|October 9, 2017
Acylated and unacylated ghrelin confer neuroprotection to mesencephalic neuronsJohanna Wagner, Franca Vulinović, Anne Grünewald, et al.
Glia|November 6, 2018
Microglial glutamate release evoked by α-synuclein aggregates is prevented by dopamineMauricio Dos-Santos-Pereira, Leonardo Acuña, Sabah Hamadat, et al.
Glia|April 18, 2018
Parkin deficiency modulates NLRP3 inflammasome activation by attenuating an A20-dependent negative feedback loopFrançois Mouton-Liger, Thibault Rosazza, Julia Sepulveda-Diaz, et al.
Journal of Neurochemistry|June 28, 2013
Probenecid potentiates MPTP/MPP+ toxicity by interference with cellular energy metabolismDaniel Alvarez-Fischer, Carmen Noelker, Anne Grünewald, et al.
Neurotoxicity Research|January 10, 2016
Doxycycline Suppresses Microglial Activation by Inhibiting the p38 MAPK and NF-kB Signaling PathwaysFlávia V Santa-Cecília, Benjamin Socias, Mohand O Ouidja, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's diseaseGünter U Höglinger, Joshua J Breunig, Candan Depboylu, et al.
Journal of Neurochemistry|October 13, 2005
The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathyGünter U Höglinger, Annie Lannuzel, Myriam Escobar Khondiker, et al.
Journal of Neurochemistry|December 17, 2003
Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in GuadeloupePierre Champy, Günter U Höglinger, Jean Féger, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Plos One|May 3, 2013
Bee venom and its component apamin as neuroprotective agents in a Parkinson disease mouse modelDaniel Alvarez-Fischer, Carmen Noelker, Franca Vulinović, et al.
Journal of Medicinal Chemistry|June 25, 2016
New 6-Aminoquinoxaline Derivatives with Neuroprotective Effect on Dopaminergic Neurons in Cellular and Animal Parkinson Disease ModelsGael Le Douaron, Laurent Ferrié, Julia E Sepulveda-Diaz, et al.
Neuroscience|October 9, 2017
Acylated and unacylated ghrelin confer neuroprotection to mesencephalic neuronsJohanna Wagner, Franca Vulinović, Anne Grünewald, et al.
Glia|November 6, 2018
Microglial glutamate release evoked by α-synuclein aggregates is prevented by dopamineMauricio Dos-Santos-Pereira, Leonardo Acuña, Sabah Hamadat, et al.
Glia|April 18, 2018
Parkin deficiency modulates NLRP3 inflammasome activation by attenuating an A20-dependent negative feedback loopFrançois Mouton-Liger, Thibault Rosazza, Julia Sepulveda-Diaz, et al.
Journal of Neurochemistry|June 28, 2013
Probenecid potentiates MPTP/MPP+ toxicity by interference with cellular energy metabolismDaniel Alvarez-Fischer, Carmen Noelker, Anne Grünewald, et al.
Neurotoxicity Research|January 10, 2016
Doxycycline Suppresses Microglial Activation by Inhibiting the p38 MAPK and NF-kB Signaling PathwaysFlávia V Santa-Cecília, Benjamin Socias, Mohand O Ouidja, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's diseaseGünter U Höglinger, Joshua J Breunig, Candan Depboylu, et al.
Journal of Neurochemistry|October 13, 2005
The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathyGünter U Höglinger, Annie Lannuzel, Myriam Escobar Khondiker, et al.
Journal of Neurochemistry|December 17, 2003
Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in GuadeloupePierre Champy, Günter U Höglinger, Jean Féger, et al.
Pageof 6